Pharmaceutical news, Pharma industry, Pharmaceutical manufacturing

Top Headlines

Europe suspends use of Mylan’s Hyderabad-made valsartan

EU authorities have detected NDEA in some batches of Mylan’s valsartan, manufactured in Hyderabad, India.

What will tip the scales towards continuous manufacturing?

A closer partnership between CDMOs and pharma companies could share the risk of innovation, suggested one pharma director.

Dr. Reddy’s stock shares rises amid recent US FDA citations

Dr. Reddy’s Laboratories site in Visakhapatnam, India, was issued a Form 483 last month, yet shares rose after a more recent audit where zero observations were noted.

CDMO partnerships must share risk and balance power, say industry representatives

Without a win-win contract in place, innovators will be driven to manufacture in-house, says JM executive.

AbbVie allows generic manufacture of HCV treatment in 99 countries

A licensing agreement with MPP will allow access to Mavyret in a number of low- and middle-income countries and territories at ‘affordable prices’.

Promotional Features

Content provided by Roquette Pharma Solutions

Introducing Roquette’s Pearlitol SW-F (wheat-free) DC mannitol for nutraceutical dosage forms

Providing on-the-go, health-conscious consumers with fast-acting, easy-to-take and affordable healthcare products is a top priority for OTC drug and nutraceutical manufacturers and marketers.